Advertisement

Il carcinoma paratiroideo

  • Maurizio IacoboneEmail author
  • Francesca Torresan
Rassegna
  • 10 Downloads

Sommario

Il carcinoma paratiroideo è un tumore raro (1% dei casi di iperparatiroidismo primitivo) e può presentarsi in modo sporadico o ereditario (nel quadro di HPT-JT Syndrome, associato a tumori mascellari). Il quadro clinico è generalmente caratterizzato da ipercalcemia grave, refrattaria al trattamento medico, severo coinvolgimento renale e osseo e, talvolta, dall’invasione delle strutture circostanti. La terapia chirurgica rappresenta il trattamento di scelta e prevede resezioni en-bloc allargate alle strutture adiacenti.

Parole chiave

Carcinoma Paratiroide Iperparatiroidismo CDC73 HPT-JT 

Notes

Conflitto di interesse

Gli autori Maurizio Iacobone e Francesca Torresan dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Supplementary material

40619_2019_515_MOESM1_ESM.doc (30 kb)
(DOC 31 kB)
40619_2019_515_MOESM2_ESM.doc (28 kb)
(DOC 28 kB)

Bibliografia

  1. 1.
    Givi B, Shah JP (2010) Parathyroid carcinoma. Clin Oncol (R Coll Radiol) 22(6):498–507 CrossRefGoogle Scholar
  2. 2.
    Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88(4):223–228 CrossRefGoogle Scholar
  3. 3.
    Iacobone M, Carnaille B, Palazzo FF, Vriens M (2015) Hereditary hyperparathyroidism-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck’s Arch Surg 400:867–886 CrossRefGoogle Scholar
  4. 4.
    Iacobone M, Masi G, Barzon L et al. (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbeck’s Arch Surg 394(5):817–825 CrossRefGoogle Scholar
  5. 5.
    Verdelli C, Corbetta S (2017) Epigenetic alterations in parathyroid cancers. Int J Mol 18(2):310 CrossRefGoogle Scholar
  6. 6.
    Talat N, Schulte KM (2010) Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol 17:2156–2174 CrossRefGoogle Scholar
  7. 7.
    Schantz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases. Cancer 31(3):600–605 CrossRefGoogle Scholar
  8. 8.
    Tan MH, Morrison C, Wang P et al. (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10(19):6629–6637 CrossRefGoogle Scholar
  9. 9.
    Fernandez-Ranvier GG, Khanasfshar E, Jensen K et al. (2007) Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110(2):255–264 CrossRefGoogle Scholar
  10. 10.
    Wei CH, Harari A (2012) Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol 13(1):11–23 CrossRefGoogle Scholar
  11. 11.
    Rozhinskaya L, Pigarova E, Sabanova E et al. (2017) Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases. Endocrinol Diabetes Metab Case Rep 2017:16-0113 Google Scholar
  12. 12.
    Gasparri G, Palestini N, Camandona M (eds) (2016) Primary, secondary and tertiary hyperparathyroidism. Updates in Surgery. Springer, Milan Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Chirurgia Endocrina, Dipartimento di Scienze Chirurgiche, Oncologiche e GastroenterologicheUniversità degli Studi di PadovaPadovaItalia

Personalised recommendations